Abstract:Human antithrombin has been crystallized by microdialysis at pH 6.7 using 18% (w/v) polyethylene glycol-4000 as precipitant. Under these conditions two crystal forms grew. The first started growing after ten days, diffracted to 3.0 A resolution and belongs to the monoclinic space group P2(1) with two molecules in the asymmetric unit and unit cell dimensions a = 70.1 A, b = 101.5 A, c = 90.5 A and beta = 105.9 A. The other crystal form took more than three months to appear, diffracted to 5.5 A and belongs to the hexagonal space group of either P6(1) or P6(5) with unit cell dimensions of a = b = 99.3 A and c = 152.9 A and two molecules in the asymmetric unit. The antithrombin redissolved from the monoclinic crystals was shown both by SDS-polyacrylamide gel electrophoresis and by protein sequence analysis to be intact while that from the hexagonal crystals was cleaved in the reactive centre loop between the P'2 and P'3 (i.e. Leu-Asn) residues. Further analysis of the intact inhibitor from the monoclinic crystals indicated that the antithrombin was present in two different conformations; an active form which could inhibit thrombin and form a stable complex with the protease, and a form which was inactive as an inhibitor and which also did not act as a substrate for thrombin. This latter form also had a low affinity for heparin and in these ways resembles latent antithrombin. The active material from the monoclinic crystals had an association rate constant with thrombin in the presence of heparin (kass) of 7.5 x 10(7) M-1 s-1 (kass for native antithrombin = 8.2 (+/- 1.0) x 10(7) M-1 s-1) indicating it still had effective heparin cofactor activity. X-ray diffraction analysis also suggests that two different protein conformations exist within the monoclinic crystals. Whereas the rotation function peak heights are equal for both molecules in the asymmetric unit using the structure of intact ovalbumin as a search model, one of the two molecules gives a much clearer signal than the other when the structures of the two cleaved serpins, alpha 1-antitrypsin and alpha 1-antichymotrypsin are used.

Crystal Structure Of Native Chicken Fibrinogen At 5.5-Angstrom Resolution

Crystal Structure of Native Chicken Fibrinogen at 2.7 Å Resolution,

Crystal structure studies on fibrinogen and fibrin

Crystal structure of fragment D from lamprey fibrinogen complexed with the peptide Gly-His-Arg-Pro-amide.

Study of the fibrinogen structure by the method of small-angle synchrotron scattering

Triclinic Lysozyme at 0.65 Å Resolution

Crystal Structure of a Cyclic Form of Bovine Pancreatic Trypsin Inhibitor.

The crystal structure of fragment double-D from cross-linked lamprey fibrin reveals isopeptide linkages across an unexpected D-D interface.

Cryo-EM structure of the human native plasma coagulation factor XIII complex

Native quaternary structure of bovine alpha-crystallin

The amino acid sequence of the α-chain of human fibrinogen

Crystal Structure of A Novel Non-Pfam Protein Pf2046 Solved Using Low Resolution B-Factor Sharpening and Multi-Crystal Averaging Methods

Photoinduced Fibrils Formation of Chicken Egg White Lysozyme under Native Conditions

Crystal Structure and Function of Human Spindlin1

Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptor

Crystallization and preliminary X-ray diffraction analysis of two conformations of intact human antithrombin

Crystal structures of a tetrahedral open pore ferritin from the hyperthermophilic archaeon Archaeoglobus fulgidus

Crystallization and Preliminary Crystallographic Analysis of the Extracellular Fragment of FcalphaRI/CD89.

Crystallization and preliminary X-ray diffraction analysis of post-fusion six-helix bundle core structure from Newcastle disease virus F protein.

Crystal structure of human coactosin-like protein at 1.9 A resolution.

Crystal structure of (Gly-Pro-Hyp)(9) : implications for the collagen molecular model